A health ministry panel Wednesday approved a plan to cut the price of Lecanemab, an Alzheimer's drug codeveloped by Japanese ...

Lecanemab and donanemab effects lasting over three years, new treatments, trials of home injections and blood tests for ...

Seven years of investigation by scientists at Harvard Medical School has revealed that the loss of the metal lithium plays a ...

A Japanese health ministry panel on Wednesday approved a plan to cut the price of Lecanemab, an Alzheimer's drug codeveloped by Japanese drugmaker Eisai Co. and US industry peer Biogen Inc., by 15 ...

Erin Kelly is likely going to forget her eight-year-old daughter Evie’s name before her little girl finishes high school.

Subtyping is what made precision medicine in cancer a reality. And for successful drug discovery in all its stages, finding ...

Lithium could help treat cases of Alzheimer’s disease, a Harvard study suggests. People with the neurodegenerative condition ...

A Harvard team reverses dementia in mice with a metal supplement, after showing that its deficiency drives the disease ...

Alzheimer's disease is the most common type of dementia. All types of dementia involve a gradual loss of functions such as ...

New research results reported at the Alzheimer’s Association International Conference® 2025 (AAIC®) advanced scientific understanding of risk, diagnosis and treatment of Alzheimer’s disease and other ...

Why does the brain of some people stay sharp into their 80s and beyond? An expert explains what 25 years of exploring the ...